Galectin Therapeutics (GALT) Return on Capital Employed Growth (1y) (2012 - 2026)
Galectin Therapeutics (GALT) Return on Capital Employed Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 1,648.00 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 31,429.00 |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,805.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 2,503.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -105.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | -3,457.00 |
| 10 | Galectin Therapeutics | 225.30 Mn | 225.30 Mn | - | -19,912.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19,912.00 |
| Dec 31, 2025 | -59,439.00 |
| Sep 30, 2025 | 131,876.00 |
| Jun 30, 2025 | -157,295.00 |
| Mar 31, 2025 | 30,115.00 |
| Dec 31, 2024 | 74,904.00 |
| Sep 30, 2024 | -92,563.00 |
| Jun 30, 2024 | 4,721.00 |
| Mar 31, 2024 | 16,094.00 |
| Dec 31, 2023 | 18,167.00 |
| Sep 30, 2023 | -8,384.00 |
| Jun 30, 2023 | -18,653.00 |
| Mar 31, 2023 | -30,038.00 |
| Dec 31, 2022 | -48,453.00 |
| Sep 30, 2022 | -17,391.00 |
| Jun 30, 2022 | -5,908.00 |
| Mar 31, 2022 | 136.00 |
| Dec 31, 2021 | -895.00 |
| Sep 30, 2021 | -5,244.00 |
| Jun 30, 2021 | -8,178.00 |